Vigadrone

Active Ingredient(s): Vigabatrin
FDA Approved: * June 21, 2018
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Vigadrone Overview

Vigabatrin, brand name Sabril, is an antiepileptic drug that inhibits the breakdown of γ-aminobutyric acid (GABA) by acting as a suicide inhibitor of the enzyme GABA transaminase (GABA-T). It is also known as γ-vinyl-GABA, and is a structural analogue of GABA, but does not bind to GABA receptors.[1] Contents 1 Medical uses 1.1 Epilepsy 1.2 Others 2 Adverse effects 2.1 Central nervous system 2.2 Gastrointestinal 2.3 Body as a whole 2.4 Teratogenicity 2.5 Senso...

Read more Vigadrone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Vigabatrin

Recent Vigadrone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Vigabatrin
  • For Solution: 500mg/packet
  • Tablet: 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vigadrone: (1 result)

Sorted by National Drug Code
  • 0245-0556 Vigadrone 50 mg/ml Oral Powder, for Solution by Upsher-smith Laboratories, LLC

Other drugs which contain Vigabatrin or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 November 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 501 S. Cherry St, Suite 1100, Denver, CO, 80246, USA